Literature DB >> 19738453

Definitive radiotherapy for carcinoma in situ of the true vocal cords.

Neil Sengupta1, Christopher G Morris, Jessica Kirwan, Robert J Amdur, William M Mendenhall.   

Abstract

PURPOSE: To report long-term rates of tumor control after radiotherapy (RT) for carcinoma in situ (CIS) of the true vocal cords (TVC).
MATERIALS AND METHODS: Thirty-seven patients with CIS of the TVC were treated curatively with megavoltage RT between July 1967 and December 2005. Most patients (28/37) were treated with cobalt-60; the remainder were treated with 2- to 6-MV photons. Small (usually 5 x 5) fields were used. Median RT dose was 60.0 Gy (range, 56.25-66.50 Gy; mean dose, 59.55 Gy) at 2.25 Gy per fraction. Approximately two-thirds of the patients (23/37) were referred for RT because of a recurrence after at least 1 stripping procedure.
RESULTS: With a mean follow-up of 9.5 years (range, 2-25 years), the 5-year rates of local control, local control with larynx preservation, and ultimate local control (including salvage surgery) were 91%, 91%, and 91%, respectively. Invasive squamous cell carcinoma developed in 4 patients (11%). Time to failure was 6 months, 12 months, 48 months, and 13 years. Two patients were surgically salvaged with a total laryngectomy, 1 with transoral laser excision, and 1 patient declined further treatment. Cause-specific survival at 5 years was 100%. No late complications were noted.
CONCLUSIONS: RT to approximately 63 Gy at 2.25 Gy per fraction, using small (5 x 5 cm) fields produces excellent results in patients with CIS of the TVC.

Entities:  

Mesh:

Year:  2010        PMID: 19738453     DOI: 10.1097/COC.0b013e3181a3194f

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  4 in total

1.  Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.

Authors:  B G Salas-Salas; D J Domínguez-Nuez; R Cabrera; L Ferrera-Alayón; M Lloret; P C Lara
Journal:  Clin Transl Oncol       Date:  2019-06-01       Impact factor: 3.405

2.  Extensive HPV-related carcinoma in situ of the upper aerodigestive tract with 'nonkeratinizing' histologic features.

Authors:  Rebecca D Chernock; Brian Nussenbaum; Wade L Thorstad; Yuling Luo; Xiao-Jun Ma; Samir K El-Mofty; James S Lewis
Journal:  Head Neck Pathol       Date:  2013-10-23

3.  Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.

Authors:  William A Stokes; Diana Abbott; Andy Phan; David Raben; Ryan M Lanning; Sana D Karam
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-06       Impact factor: 7.038

4.  Outcome of Early-Stage Glottic Laryngeal Carcinoma Patients Treated with Radical Radiotherapy Using Different Techniques.

Authors:  Oguz Cetinayak; Ersoy Dogan; Ahmet Kuru; Nesrin Akturk; Barbaros Aydin; Cenk Umay; Ilhami Er; Fadime Akman
Journal:  J Oncol       Date:  2019-11-06       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.